
Ashish Saxena
Thoracic medical oncologist at Weill Cornell Medicine; Section Chief of the Thoracic Medical Oncology Service, specializing in lung cancer and small cell lung cancer research and care.
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
Sep 17, 2026
New Hope in Small Cell Lung Cancer: The Research Shaping What's Next
7:27
7:33
7:50
8:01

Wendy BrooksHOST
What are some of these newer treatment approaches giving researchers more hope today?

Ashish SaxenaGUEST
For a long time, sort of chemotherapy was the main treatment option and that really all there was.

Ashish SaxenaGUEST
And then sort of the most common Game-changing, I would say, treatment was the introduction of immunotherapy, which are treatments that we give that help your own immune system to also attack the cancer.

Ashish SaxenaGUEST
And that's where we started to make progress, harnessing the immune system to also kill the cancer cells, along with chemotherapy.